Format

Send to

Choose Destination
See comment in PubMed Commons below
EMBO Rep. 2011 Jun;12(6):534-41. doi: 10.1038/embor.2011.65. Epub 2011 May 13.

Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS.

Author information

1
State Key Laboratory of Genetic Engineering, School of Life Science, Novartis-Fudan Joint Research Laboratory, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.

Abstract

Mitochondria manganese superoxide dismutase (SOD2) is an important antioxidant enzyme, deficiency of which is associated with various human diseases. The known primary regulation of SOD2 is through transcriptional activation. Here, we report that SOD2 is acetylated at Lys 68 and that this acetylation decreases SOD2 activity. Mitochondrial deacetylase SIRT3 binds to, deacetylates and activates SOD2. Increase of reactive oxygen species (ROS) levels stimulates SIRT3 transcription, leading to SOD2 deacetylation and activation. SOD2-mediated ROS reduction is synergistically increased by SIRT3 co-expression, but is cancelled by SIRT3 depletion. These results reveal a new post-translational regulation of SOD2 by means of acetylation and SIRT3-dependent deacetylation in response to oxidative stress.

PMID:
21566644
PMCID:
PMC3128277
DOI:
10.1038/embor.2011.65
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center